| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate |
2006-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf9e1f21b27d17675587daee93af6f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76663f5e26884151093bd40381f27211
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a69fe870576237c05f12d156c9866c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef4e07f89e7a2d67b02fc964bb8f9e63 |
| publicationDate |
2006-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006213713-A |
| titleOfInvention |
Dosage form of cholesteryl ester transfer protein inhibitor and HMG-CoA reductase inhibitor |
| abstract |
PROBLEM TO BE SOLVED: To provide a safe and effective dosage form for delivering a combination of a 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) inhibitor and a cholesteryl ester transfer protein inhibitor. A dosage form comprising a solubility-improved form of a cholesteryl ester transport protein inhibitor and an HMG-CoA reductase inhibitor, wherein the HMG-CoA reductase inhibitor is released immediately and the controlled release of the cholesteryl ester transport protein inhibitor And dosage forms that provide immediate release. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014501240-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015522626-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017209158-A1 |
| priorityDate |
2005-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |